Načítá se...
Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
Gastric cancer (GC) is fifth most frequently diagnosed cancer and second leading cause of cancer in China. More than 80% of GC are diagnosed at an advanced stage due to low uptake rate of invasive screening method. The performance of methylated SFRP2 test was evaluated in 236 plasma samples, includi...
Uloženo v:
| Vydáno v: | Cancer Control |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218304/ https://ncbi.nlm.nih.gov/pubmed/32379490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820922559 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|